Back to results
US 2025/0017936 A1Published application
Cell-potent bisubstrate inhibitors for nicotinamide n-methyltransferase (nnmt) and uses thereof
AssigneePurdue Research Foundation
InventorsRong HUANG, Iredia IYAMU
Life of this patent
Estimating the term…
Abstract
A compound with the following formula (I) or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising a compound of formula (I); and a method of inhibiting nicotinamide N-methyItransferase in a patient in need thereof, such as a patient with cancer.
Claims18
A compound having the formula (I):
- or a pharmaceutically acceptable salt thereof, wherein,
- R1 is an alkyl, a haloalkyl, an alkenyl, an alkynyl, an aminoalkanoic acid, an acyl, an arylalkylacyl, an arylacyl, a cycloalkyl, a heterocyclyl, an aryl, a heteroaryl, an arylalkyl, or a heteroarylalkyl;
- R2, R3, R4, and R5 are, independently, hydrogen, a halo, a haloalkyl, an alkyl, an amino, an alkylamino, or an alkylaminoalkyl;
- and
- R6, R7, and R8 are, independently, hydrogen, methyl, hydroxyl, methoxyl, trifluoromethyl, or a halo;
- and
- R9 is an amine or methyl.
4 more elements
4-10. (canceled)
A compound of the formula:
- or a pharmaceutically acceptable salt thereof. or a pharmaceutical composition comprising same, together with one or more pharmaceutically acceptable diluents, excipients, or carriers.
Dependencies are inferred from the claim text.